Welcome to our media centre, here you will find a range of resources including our press releases, news updates and information related to the conferences and events we attend each year.
These press releases and news updates are intended for media and investors only.
UPCOMING CONGRESS
22 - 25 FEBRUARY, 2026
CROI 2026 CONFERENCE
We are excited to attend The Conference on Retroviruses and Opportunistic Infections (CROI) in Denver, Colorado. CROI is a prominent annual scientific meeting focused on the latest research in HIV/AIDS and related opportunistic infections.
27 OCTOBER 2025
ViiV Healthcare launches ‘Risk to Reasons’ initiative in the UK to empower women to take control of their HIV prevention choices
21 OCTOBER 2025
Global Fund welcomes renewed commitment from GSK and ViiV Healthcare to expand community-led health solutions with £6 million joint pledge ahead of 8th Replenishment
17 OCTOBER 2025
NICE issues positive recommendation for ViiV Healthcare’s cabotegravir for PrEP, the first and only long-acting HIV prevention option to be reimbursed in England and Wales
15 OCTOBER 2025
ViiV Healthcare’s CLARITY study shows long-acting cabotegravir more acceptable than lenacapavir injections after a single dose, with 90% preferring cabotegravir
09 OCTOBER 2025
ViiV Healthcare showcases breadth of clinical and real-world evidence at EACS and IDWeek 2025
14 JULY 2025
ViiV Healthcare extends voluntary licensing agreement with Medicines Patent Pool to enable access to innovative long-acting injectable HIV treatment
14 JULY 2025
ViiV Healthcare data show 89% of treatment-naïve people with HIV choose to switch to long-acting injectable Vocabria + Rekambys from daily pills after achieving rapid viral suppression
08 JULY 2025
ViiV Healthcare presents new data demonstrating positive real-world impact of its innovative long-acting injectables for HIV at IAS 2025
Media contacts
Media contact details for our global headquarters and USA. For press contacts in our local operating companies please visit our country websites.
If you have a media query please contact us
Global Press Office
Rachel Jaikaran
Head of Global Communications ViiV Healthcare
Tel: +44 7823 523 755
NP-GBL-HVX-COCO-220039 | October 2025
If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the GSK Reporting Tool link https://gsk.public.reportum.com/. By reporting side effects, you can help provide more information on the safety of this medicine.
If you are from outside the UK, you can report adverse events to GSK/ ViiV by selecting your region and market, here.
